← Medication Database
Oncology

Loqtorzi

Generic: toripalimab-tpzi

Manufacturer: Coherus Biosciences  ·  Program: LOQTORZI Solutions Patient Assistance Program

Apply for Assistance

Eligibility Criteria

Insurance Requirement

Uninsured or functionally underinsured (not government-funded programs)

Residency

US resident

Income Threshold

Up to 500% FPL

Adjusted annual household income ≤500% FPL for uninsured or functionally underinsured

Program Information

Processing Time

4–8 weeks

Delivery Method

shipped to patient or physician office

Application Method

Multiple

Reauthorization

Required — annual

Typically Required Documents

ProvisionRX prepares and organizes all required documentation as part of your enrollment management. This list is provided for informational purposes.

  • Income documentation or consent for credit check
  • Signed consent form

Indicated For

recurrent locally advanced or metastatic nasopharyngeal carcinoma

About This Medication

# LOQTORZI Solutions Patient Assistance Program Patient Guide: How to Get Loqtorzi (toripalimab-tpzi) at Low or No Cost Loqtorzi (toripalimab-tpzi) is an FDA-approved immunotherapy for adults with nasopharyngeal carcinoma (NPC), a type of head and neck cancer. The **LOQTORZI Solutions Patient Assistance Program** from **Coherus Biosciences** provides **Loqtorzi at no cost** to eligible uninsured or functionally underinsured patients facing financial hardship.[1][5] ## About Loqtorzi (toripalimab-tpzi) Loqtorzi is a prescription medicine used to treat adults with **nasopharyngeal carcinoma (NPC)**, which affects the nasopharynx (upper part of the throat behind the nose). It works as an immune checkpoint inhibitor, helping your immune system fight cancer cells.[3][8] **Approved uses:** - In combination with **cisplatin and gemcitabine** as **first-line treatment** for **metastatic or recurrent, locally advanced NPC**. - As a **single agent** for **recurrent unresectable or metastatic NPC** after disease progression on or after platinum-containing chemotherapy.[2][3][5] **How it's given:** Loqtorzi is administered as an **IV infusion** (through a vein) by a nurse at your doctor's office or infusion center. Treatment often starts with 6 cycles of Loqtorzi plus chemotherapy every 3 weeks, followed by Loqtorzi alone (chemo-free) for up to 24 months if effective.[8] **Important safety note:** Loqtorzi can cause serious side effects like immune-related problems (e.g., lung, liver, or thyroid issues), infusion reactions, or Guillain-Barré syndrome. Your doctor will monitor you closely and may adjust treatment.[8][9] Always discuss with your oncologist if Loqtorzi is right for you. ## Who Qualifies for the Program? This program is for **uninsured** or **functionally underinsured** patients (those with insurance that doesn't adequately cover Loqtorzi, but **not** government-funded like Medicare, Medicaid, VA, or TRICARE).[1][5][7] You must meet **all** criteria: - US resident, age 18+. - Under care of a US-licensed provider in an outpatient setting. - Diagnosis and dosing match FDA-approved indications (or provider deems medically necessary).[5] - **Adjusted annual household income ≤500% of the Federal Poverty Level (FPL)**.[5][10] - Provide income proof or consent to credit check; sign consent form.[5] **Note:** Program covers only the drug cost, not administration or office visits. Not valid where prohibited; Coherus may change/terminate anytime.[5] ## Income Eligibility Breakdown Eligibility is based on **household size** and **adjusted annual income** at or below **500% FPL**. Use the table below for 2026 guidelines (FPL updates annually; verify current at [healthcare.gov](https://www.healthcare.gov)). | Household Size | Max Annual Income (500% FPL) | |----------------|------------------------------| | 1 (Individual) | $73,950 | | 2 (Couple) | $100,000 | | 3 | $126,050 | | 4 | $152,100 | | +1 per member | +$26,050 | *Examples: A single person earning ≤$73,950 qualifies; a family of 4 ≤$152,100. Include all household income (taxable + some nontaxable). Deduct certain expenses for 'adjusted' income.*[5][10] ## Insurance Requirements - **Eligible:** Uninsured or **functionally underinsured** (high copays/deductibles make Loqtorzi unaffordable, but no government coverage).[1][5] - **Not eligible:** Medicare, Medicaid, Medicare Advantage, VA, TRICARE, or other government programs. Commercial insurance patients may use the separate Co-Pay Savings Program (up to $30,000/year, $0/dose possible).[4][5] If insurance changes to government-funded, report immediately to (844) 483-3692.[4] ## Step-by-Step Application Process 1. **Talk to your doctor:** Confirm Loqtorzi prescription and eligibility. Your oncologist starts the process.[2][5] 2. **Contact LOQTORZI Solutions:** Call **(844) 483-3692** Mon-Fri. Multiple methods: phone, HCP portal, or forms.[5][7] 3. **Submit documents:** - Proof of income (tax returns, pay stubs, W-2s) **or** consent for credit check. - Signed consent form. - Prescription, proof of no/poor insurance.[5] 4. **Doctor completes forms:** Includes diagnosis, dosing, and medical necessity.[5] 5. **Wait for approval:** If approved, Loqtorzi ships free.[1] Applications are reviewed quickly; **reauthorization** needed periodically.[5] ## Timeline and Delivery - **Processing:** Typically days to weeks (exact time varies; call for status).[1] - **Delivery:** Ships directly to **you or your doctor's office** at no cost.[5] - **Refills:** **Reauthorization required**; resubmit proof of ongoing need/response to therapy.[2][5] Track via phone support. ## Alternatives if Denied or Ineligible - **Co-Pay Savings Program:** For commercial insurance; up to $30,000/year assistance.[4][5][6] - **Other PAPs:** Check rxassist.org or needymeds.org.[10] - **State programs, foundations:** CancerCare, Patient Access Network (PAN). - **Discuss with oncologist:** Biosimilars (none currently); generics unlikely; trial enrollment.[2] - **Appeal denial:** Provide more docs or updated income.[5] **No biosimilar alternatives listed for Loqtorzi.**[program data] ## Disclaimer This guide is for informational purposes only and based on program details as of March 2026. Eligibility, terms, and availability can change. Coherus Biosciences reserves the right to modify/terminate without notice. Not a guarantee of coverage. Consult your healthcare provider and call (844) 483-3692 for personalized advice. Read full Prescribing Info and Medication Guide. Report side effects to FDA at 1-800-FDA-1088.[1][5][8]

Program information last verified: March 25, 2026

Ready to apply for Loqtorzi assistance?

ProvisionRX manages the complete application process. Start your application in about 15 minutes.

Start My ApplicationBrowse All Medications